-
NASH patients are under severe oxidative stress
due to free fatty acids ends
with fibrosis and finally cirrhosis .


Also you can see
Some Headline about Liver

Non-alcoholic fatty liver disease (NAFLD)
is associated with obesity, abnormal glucose tolerance and dyslipidemia. It has been described as the hepatic manifestation of the metabolic syndrome.

Fatty liver (steatosis) when progress
with inflammation it becomes much risky, ends with non-alcoholic steatohepatitis (NASH).
Also more Details
Some Studies about Liver

Metabolic Syndrome
- Type 2 diabetes or impaired glucose tolerance.
- Central obesity.
- Dyslipidemia.
- Raised blood pressure.
- Central obesity.
- Dyslipidemia.
- Raised blood pressure.

Risk Factors
- Hepatitis B & C and HIV.
- Patients under chronic medicine.
- Starvation or rapid weight loss, including following gastric bypass surgery.
- Body builders with high protein intake.
- Polycystic ovary syndrome.
- Patients under chronic medicine.
- Starvation or rapid weight loss, including following gastric bypass surgery.
- Body builders with high protein intake.
- Polycystic ovary syndrome.
Sulfad Concept
- SULFAD is a very effective & unique phytopharmaceutical brand.
- SULFAD is the only formula which can manage underlying causes of NASH.
- SULFAD shows synergistic effects
due to having 4 bioactive ingredients

-
Cynara Extract
-
Curcuma Extract
-
Liquoruce Extract
-
Thistlemilk Extract

0
+
Awards Win

0
K
Patients

0
%
Treatment Efficiency

0
+
Years of experience

Contact Us
Have Questions?
Get in Touch!
Enter Your Mail For subscribe
Contact Us
- Riyadh ,Saudi Arabi
- +966 11 460 3099
- +966 11 460 3163
- info@Pharma.com.sa